Milestone Scientific (NYSE:MLSS – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.
Institutional and Insider Ownership
5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 9.2% of Milestone Scientific shares are owned by company insiders. Comparatively, 2.4% of IceCure Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Risk and Volatility
Milestone Scientific has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Milestone Scientific | 0 | 0 | 1 | 0 | 3.00 |
| IceCure Medical | 2 | 0 | 3 | 0 | 2.20 |
Milestone Scientific currently has a consensus target price of $1.00, suggesting a potential upside of 107.47%. IceCure Medical has a consensus target price of $52.50, suggesting a potential upside of 1,816.06%. Given IceCure Medical’s higher probable upside, analysts plainly believe IceCure Medical is more favorable than Milestone Scientific.
Earnings and Valuation
This table compares Milestone Scientific and IceCure Medical”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Milestone Scientific | $9.42 million | 4.53 | -$6.93 million | ($0.04) | -12.05 |
| IceCure Medical | $3.38 million | 2.78 | -$15.06 million | ($8.52) | -0.32 |
Milestone Scientific has higher revenue and earnings than IceCure Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Milestone Scientific and IceCure Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Milestone Scientific | -52.01% | -60.26% | -40.23% |
| IceCure Medical | -427.67% | -174.26% | -112.58% |
Summary
Milestone Scientific beats IceCure Medical on 11 of the 14 factors compared between the two stocks.
About Milestone Scientific
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
